Focus on a higher level to drive industrial upgrading-Chuangxin Tongheng signed a new pr•oject with Haizheng Pharmaceutical to boost the pro♣cess of new drug listing.

 

2018In March 1993, Beijing Chuangxin Tongheng Technology Co., Ltd. ≈and Haizheng Pharmaceutical (Hangzhou) Co., Ltd. formall$y signed a new project cooperation agreement based on the concept of "πcooperation, complementarity and win-win". The total investment of the project is nearl™y 0.1 billion yuan. The two sides will carry out higher-level cooperation on ind∞ustrialized preparative liquid chromatography systems, promote the strategy of national medicine$ innovation and internationalization, and help Haizheng realize the sustainablεe development of medicine China dream and achieve win-win cooperation.

As a strategic emerging industry that my country will focus on cultivating and developing in ©the future, the biomedical industry has also entered a stage of rapid growth. Drug₹s have a great relationship with human health and the improvement of quality of life. Many drugΩs are affected by purity, and their efficacy cannot be fully ut$ilized., Even produce toxic and side effects. The appl✔ication of industrial preparative liquid chromatog raphy in the pharmaceutical industry has become the mainstream↓ of drug separation and purification technology.

As a trusted partner of pharmaceutical customers, Chuangxin Tongheng will also tak¥e this new project cooperation as an opportunity to implement an innovative dev elopment strategy, transform innovative resources into nec↔essary advantages for development, promote the transformation and upgrading σof economic development, leapfrog and catch-up, and at the same time provide Haizheng Pharmaceu¶tical with all-round support in the field of biopharm✘aceutical separation and purification.

Haizheng Pharmaceutical is the leader of China's pharmaceutical industry, and Chuang✘xin Tongheng is also the leader of work preparation chromatography. Clo ser cooperation between the two parties can better play their res pective advantages, achieve win-win cooperation, and contribute t♠o the development of China's biopharmaceuticals. Important coγntribution.

 

About Innovation Tongheng

Beijing Innovation Tongheng Technology Co., Ltd. was establ"ished on December 8, 2000. It is a national high-tech enterprise specia≈lizing in the research, development, production and sales of liquid chromatogr∏aphs. The company adheres to the enterprise development tenet of "ta→king liquid chromatography technology as the core, constantly expanding the application field a∑nd meeting the different needs of customers". It is committed to developing chrom€atographs and material purification equipment for analysis, preparation and indu✘strial-grade needs. In the field of chromatography products, it ha​s become one of the largest research and manufacturing enterprises in China.

At present, the company's products have been widely used Ωin various fields such as drug analysis, food safety, environmental pollution, life sciences, indu₹strial preparation, etc., and continue to provide customers with innovative  products and services, and according to the actual needs of customers, tδhey can provide customers with preliminary process exploration and process The pilot scale-up, <the overall scheme design and construction of industrial-grade equi"pment, has become the largest domestic liquid phase preparation eq←uipment research and development, manufacturing and overall solution enterpr↓ise.

 

About Haizheng Pharmaceutical

Zhejiang Haizheng Pharmaceutical Co., Ltd., headquartered in Taizhou ₽City, Zhejiang Province, has more than 9000 employees. In July 2000, "Hai÷zheng Pharmaceutical" A shares were listed on the Shanghai Stock ​Exchange (stock code: 600267). Haizheng has successively won awards such as "National Hi$gh-tech Enterprise", the country's first batch of "Innovative Enterpris☆es", and "Technological Innovation Demonstration Enterprises". It has €also won the "Top Ten Export-oriented Enterprise Brands", "Top Ten Innovative Enter↔prise Brands" and "Top 500 National Manufacturing Industry". In≤ 2014, the Fortune China 500 list was listed in the first ba→tch of "three" enterprises in Zhejiang Province. "Haizheng" ↓and "HISUN" are recognized as well-known trademarks in China.

Zhejiang Haizheng Pharmaceutical Co., Ltd. is a top supplier of APIs and preparations at home and aγbroad. It is mainly engaged in the research, production and marketing of APIs and p∑reparations in the fields of anti-tumor, anti-infection,∑ cardiovascular, endocrine, immunosuppression, antidepressant, orthopedics, et♣c. Business covers more than 70 countries and regions aroun↕d the world, and has formed its own characteristics and advantages in th₩e industrialization of characteristic APIs and high-end preparations.